Promotion of access to essential medicines for Non-Communicable Diseases: Practical implications of the UN Political Declaration [PDF]
Lancet, The, 2013 Access to medicines and vaccines to prevent and treat non-communicable diseases (NCDs) is unacceptably low worldwide. In the 2011 UN political declaration on the prevention and control of NCDs, heads of government made several commitments related to ...
Abdraimova +60 more
core +5 more sources
25 years of the WHO essential medicines lists: progress and challenges. [PDF]
Lancet, The, 2003 The first WHO essential drugs list, published in 1977, was described as a peaceful revolution in international public health. The list helped to establish the principle that some medicines were more useful than others and that essential medicines were ...
't Hoen +22 more
core +3 more sources
Signal of harm in morphine use in adults with acute pulmonary oedema: A rapid systematic review
South African Medical Journal, 2023 Background. Heart failure affects nearly 65 million people globally, resulting in recurrent hospital admissions and substantial healthcare expenditure.
C Hendrikse +6 more
doaj +1 more source
International meeting: New diagnostic tests are urgently needed to treat patients with Chagas disease. [PDF]
, 2008 Trypanosoma cruzi infection is often not detected early on or actively diagnosed, partly because most infected individuals are either asymptomatic or oligosymptomatic.
Campaign for Access to Essential Medicines
core +3 more sources
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2022 Background: Tuberculosis (TB) remains a major cause of morbidity and mortality globally despite effective treatments. Along with high-quality health services, essential medicines are a key tool in curbing TB related mortality.
Darshanand Maraj +2 more
doaj +1 more source
Фармацевтичний журнал, 2020 Market access for pharmaceuticals is a set of strategies, activities and processes developed by pharmaceutical companies to provide affordable medicines at appropriate fair prices in a particular health care system.
O. B. Piniazhko +5 more
doaj +1 more source
Can NGOs Regulate Medicines Markets? Social Enterprise in Wholesaling, and Access to Essential Medicines. [PDF]
, 2011 Citizens of high income countries rely on highly regulated medicines markets. However low income countries' impoverished populations generally struggle for access to essential medicines through out-of-pocket purchase on poorly regulated markets; results ...
Chaudhuri, Sudip +2 more
core +4 more sources
The right to health as the basis for universal health coverage : a cross-national analysis of national medicines policies of 71 countries [PDF]
, 2019 Persistent barriers to universal access to medicines are limited social protection in the event of illness, inadequate financing for essential medicines, frequent stock-outs in the public sector, and high prices in the private sector.
Alexandrov, Nikita V +2 more
core +2 more sources
Legislating for universal access to medicines : a rights-based cross-national comparison of UHC laws in 16 countries [PDF]
, 2019 Universal health coverage (UHC) aims to ensure that all people have access to health services including essential medicines without risking financial hardship. Yet, in many low- and middle-income countries (LMICs) inadequate UHC fails to ensure universal
Alexandrov, Nikita V +2 more
core +1 more source
Laudato Si’: a bridge towards access to medicines
Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia, 2018 Pope Francis’ Encyclical Laudato Si’, albeit not explicitly, has drawn attention worldwide to the access to medicines as a fundamental human right, as it raises awareness about the current situation of the world and the poor.
Jorge Antonio Zepeda Bermudez +6 more
doaj +7 more sources